According to the report, the dry eye disease diagnostic devices market in the U.S. was valued at US$ 58.3 Mn in 2020 and is projected to expand at CAGR of 4.4% from 2021 to 2031.
Albany NY, United States: U.S. Dry Eye Disease Diagnostic Devices Market: Introduction
According to the report, the dry eye disease diagnostic devices market in the U.S. was valued at US$ 58.3 Mn in 2020 and is projected to expand at CAGR of 4.4% from 2021 to 2031. Dry eye disease diagnostic devices include anterior segment OCT (AS-OCT), meibography device, corneal topographer, and osmolarity testing device.
Read Report Overview – https://www.transparencymarketresearch.com/us-dry-eye-disease-diagnostic-devices-market.html
The usage of dry eye disease diagnostic devices can be classified based on the parameter measured into tear film osmolarity, tear turnover, functional visual acuity, tear volume, tear film stability, tear film composition, ocular biomarkers, and others.
Rise in Prevalence and Incidence Rates of Dry Eye Disease in U.S.
In the U.S., dry eye disease is considered a critical and significant public health issue. An article published in the American Journal of Ophthalmology stated that the overall estimated prevalence of dry eye disease was 5.28% in the U.S. between 2003 and 2015. It also indicated that the prevalence and incidence vary from 5% to 50%, and it is rising due to higher incidence of some risk factors and gradual increase in the geriatric population. Hence, rise in prevalence of dry eye disease is anticipated to drive the market.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=84250
Rise in prevalence and incidence rates of dry eye disease and surge in geriatric population increase the risk of dry eye diseases in the U.S., which, in turn, augments the market in the country.
Meibography Device Segment to Lead U.S. Dry Eye Disease Diagnostic Devices Market
In terms of device type, the dry eye disease diagnostic devices market in the U.S. has been classified into meibography device, corneal topographer, anterior segment OCT (AS-OCT), osmolarity testing device, ocular surface thermographer, interferometer, fluorophotometer, and others. The meibography device segment is expected to account for major share of the market in the U.S. in 2031. The segment is likely to expand at a CAGR of 3.8% during the forecast period. Meibomian gland disease is considered the primary cause of evaporative dry eye disease. This drives usage of meibography devices in the diagnosis of dry eye.
Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84250
Diagnostic Centers to be Key End-user
Based on end-user, the dry eye disease diagnostic devices market in the U.S. has been divided into hospitals, diagnostic centers, ophthalmology centers/clinics, and others. The diagnostic centers segment is projected to account for major share of the market in the U.S. in 2031. The segment is anticipated to expand at a CAGR of 4.5% from 2021 to 2031.
Rise in prevalence of dry eye disease in the U.S., increase in ophthalmology group practice, multi-subspecialty group, single-subspecialty group, and surge in frequency of patients for diagnosis of dry eye disease in these centers propel the segment.
Make an Enquiry before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=84250
Competition Landscape
Key players operating in the dry eye disease diagnostic devices market in the U.S. include Johnson & Johnson Services, Inc., OCULUS Optikgeräte GmbH, Carl Zeiss Meditec AG, TearLab Corporation, Optovue, Inc., AXIM Biotechnologies, Topcon Corporation, Quantel Medical, Essilor Instruments, I-MED Pharma, Inc., Box Medical Solutions, Inc., and NIDEK CO., LTD.
Browse more Reports by Transparency Market Research:
Turner Syndrome Treatment Market: Increase in patient awareness, rising number of prenatal genetic testing, rise in healthcare awareness, and increase in investment in research and developments are the factors that are anticipated to drive the global Turner Syndrome market.
Self-assembling Vaccines Market: The global self-assembling vaccines market is primarily driven by significant investments in the development of self-assembling vaccines for coronavirus and increase in number of academic & research institutes studying vaccine usage for coronavirus.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/